Antiphosphatidylserine Antibodies and Clinical Outcomes in Patients With Acute Ischemic Stroke.

Abstract

BACKGROUND AND PURPOSE Antiphosphatidylserine antibodies (aPS) have been associated with the risk of ischemic stroke. However, it remains unclear whether aPS will influence clinical outcomes in patients with acute ischemic stroke. METHODS A total of 3013 patients with acute ischemic stroke recruited from 26 hospitals across China from August 2009 to May… (More)

Topics

3 Figures and Tables

Cite this paper

@article{Bu2016AntiphosphatidylserineAA, title={Antiphosphatidylserine Antibodies and Clinical Outcomes in Patients With Acute Ischemic Stroke.}, author={Xiaoqing Bu and Hao Peng and Chongke Zhong and Tan Xu and Tian Xu and Yanbo Peng and Chung-Shiuan Chen and Jinchao Wang and Zhong L Ju and Qunwei Li and Deqin Geng and Yingxian Sun and Dongsheng Zhang and Jintao Zhang and Jing Chen and Yonghong Zhang and Jiang He}, journal={Stroke}, year={2016}, volume={47 11}, pages={2742-2748} }